Join the 'Atripla' group to help and get support from people like you. How it works
Atripla Blog
| Tweet |
HIV Drug Tenofovir Safe During Pregnancy, Study Suggests
Posted 3 May 2012 by Drugs.com
THURSDAY, May 3 – The use of the anti-HIV drug tenofovir during pregnancy appears to be safe for infants, new research suggests. In combination with other anti-HIV drugs, tenofovir (Viread) is the first line of treatment for adults with HIV, the virus that causes AIDS. These findings should reassure pregnant women who are taking tenofovir, the researchers said. The study was conducted by the U.S. National Institutes of Health network because previous studies showed that laboratory animals exposed to tenofovir in the womb were smaller at birth than those that were not exposed to the drug. The new study included 2,000 infants born to HIV-positive mothers between 2003 and 2010 in the United States. Infants born to mothers who took tenofovir during pregnancy did not weigh less at birth and did not have shorter length than those born to women who did not take the drug. At 1 year of age, ... Read more
Related support groups: HIV Infection, Atripla, Truvada, Complera, Viread, Tenofovir, Emtricitabine/lopinavir/ritonavir/tenofovir, Emtricitabine/rilpivirine/tenofovir, Efavirenz/Emtricitabine/Tenofovir, Emtricitabine/nelfinavir/tenofovir, Emtricitabine/Tenofovir
Anti-HIV Drugs May Help Prevent Spread of Virus
Posted 27 May 2010 by Drugs.com
THURSDAY, May 27 – People who are HIV-positive can lower their risk for transmitting the virus to their partners by 90 percent by taking antiretroviral drugs, new research has found. Antiretroviral drug therapy helps reduce HIV levels in the infected person's blood, which in turn makes the person less infectious to others. The drugs are commonly taken in the United States by people with HIV, the virus that causes AIDS. In the new research, published online May 26 in The Lancet, investigators studied more than 3,400 heterosexual couples in seven African countries. In each couple, one person was infected with HIV and the other was not. No one in the study was taking antiretroviral drugs. Health workers counseled the couples about preventing HIV transmission and followed up with them for two years. During that time, periodic blood tests measured HIV levels in the blood, and people were ... Read more
Related support groups: HIV Infection, Atripla, Truvada, Baraclude, Kaletra, Norvir, Hepsera, Combivir, Ritonavir, Lexiva, Viread, Norvir Soft Gelatin, Entecavir, Epivir, Nevirapine
AIDS Drugs Don't Need Routine Lab Monitoring
Posted 9 Dec 2009 by Drugs.com
WEDNESDAY, Dec. 9 – In a finding that has implications for how the AIDS virus is treated in Africa, new research suggests that antiretroviral drugs can be given without routine monitoring by lab tests. But tests of immune-system function might still be a good idea to monitor the progression of the disease and guide the second year of treatment, the study authors report. Patients with HIV, the virus that causes AIDS, often receive drug treatment in Africa without routine laboratory monitoring. In the study, published online Tuesday in advance of publication in a future print issue of The Lancet, researchers tried to determine if that's a bad idea. They studied 3,316 HIV-positive adults who were assigned to monitoring in both the doctor's office and the laboratory or only in the doctor's office. The patients were studied in Uganda and Zimbabwe. "The results clearly show that first-line ... Read more
Related support groups: HIV Infection, Atripla, Truvada, Kaletra, Viread, Norvir, Lexiva, Norvir Soft Gelatin, Ritonavir, Reyataz, Tenofovir, Efavirenz, Atazanavir, Prezista, Sustiva